Details of issuance or disposal
Exercise status of the Eighth Series of Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clause)
1,140,000 new shares (0 treasury shares transferred)
The lower thin line represents the existing number of shares to which these shares will be added.
1,140,000 shares delivered since the beginning of the month. The ratio to the number of issued shares as of the end of the month preceding the relevant month, 10,512,901 shares, is approximately 10.8% (the document does not state a ratio).
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise status of the Eighth Series of Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clause) |
| Number of shares to be issued or disposed of | 1,140,000 new shares (0 treasury shares transferred) |
| Intended allottee | EVO FUND (the allottee at the time of issuance on 12 December 2025) |
| Dilution Rate | 1,140,000 shares delivered since the beginning of the month. The ratio to the number of issued shares as of the end of the month preceding the relevant month, 10,512,901 shares, is approximately 10.8% (the document does not state a ratio). |
| Total number of issued shares | 10,512,901 shares (as of the end of the month preceding the relevant month) → Not disclosed |
| Basis for determining the amount to be paid | Subject to an exercise price adjustment clause. The exercise price on each exercise date is stated as ¥620, ¥632, ¥630 and other amounts, but the basis for calculation and discount rate are Not disclosed. |
| Exercise price | Subject to an exercise price adjustment clause. The exercise period and the floor for adjustments are Not disclosed. |
| Number of Stock Acquisition Rights | Total issued: 85,000 rights; exercised since the beginning of the month: 11,400 rights; currently unexercised: 61,000 rights |
| Most recent equity financing | Timing 12 December 2025 / Type Eighth Series of Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clause) / Amount Not disclosed |
Items this document does not state (19)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Eighth Series of Stock Acquisition Rights issued on 12 December 2025 were exercised on a large scale during the period from 2 March to 18 March 2026.